BMAL1 and temporal lobe epilepsy: In patients with hippocampal sclerosis, a common pathology in temporal lobe epilepsy, levels of BMAL1 and PCDH19 are significantly lower compared to patients without sclerosis; however, whether these molecular changes were due to seizure activity or the sclerotic lesion itself are unclear (Wu et al., 2021).